	ProCDNet: prostate cancer detection network using quantum machine learning with enhanced addax optimization. Sci Rep Prathap MR, Vairavel KS, Kumar C, Alwabli A. PMID: 42414364 [PubMed - as supplied by publisher]
	Abscopal responses following stereotactic ablative radiotherapy during immune checkpoint inhibitor therapy in metastatic renal cell carcinoma: protocol for the prospective multicentre observational AURICRE study in Japan. BMJ Open Chen Z, Onishi H, Mitsui T, Nakao A, Yokomichi H, Tsukahara M, Mochizuki S, Marino K, Komiyama T. PMID: 42414009 [PubMed - in process]
	Study of benign prostatic hyperplasia and androgen pathway manipulation on lung cancer survivals. J Adv Res Lee PH, Cheng PT, Celik A, Lien CY, Oner M, Chen MC, Tseng JS, Huang YH, Hsu YW, Hsu KH, Hsieh JT, Yang TY, Lin H. PMID: 42413655 [PubMed - as supplied by publisher]
	An Interface-Regulated Electrochemical Biosensing Platform Based on the Cascade Amplification of Primer Exchange Reaction and CRISPR/Cas12a for Noninvasive Bladder Cancer Diagnosis. Anal Chem Yu L, Liu T, Cai Y, Gai Y, Liu H, Fang L, Ma Y, Zhou C, Ye X, Liang B. PMID: 42414241 [PubMed - as supplied by publisher]
	Evidence Thresholds for Novel Therapeutic Strategies in Prostate Cancer: A Consensus Statement from the Prostate Cancer Committee of the French Urological Association. Fr J Urol Baboudjian M, Barret E, Brureau L, Fiard G, Fromont G, Olivier J, Dariane C, Mathieu R, Peyrottes A, Roubaud G, Renard-Penna R, Sargos P, Supiot S, Turpin L, Rouprêt M, Ploussard G. PMID: 42413772 [PubMed - as supplied by publisher]
	Magnetic Resonance Imaging-Based Artificial Intelligence in Predicting Prostate Cancer Biochemical Recurrence: Systematic Review and Meta-Analysis. J Med Internet Res Jin Y, Yuan T, Chen Z. PMID: 42412916 [PubMed - indexed for MEDLINE]
	[Overtreatment of localized prostate cancer in older men-do we need aÂ new definition of clinical significance?]. Urologie Umbehr M, Manseck A, Stein J, Fröhner M, Fiebig C, Piotrowski A, Schlögl M, Wiedemann A. PMID: 42412168 [PubMed - as supplied by publisher]
	PSMA expression: enhancing prostate cancer diagnosis at the biopsy stage. Minerva Urol Nephrol Leonardi R, Mazza M, Nicolini F, Borges DE Souza P, Lupo A, DI Dio M, Calarco A, Mantica G, Ambrosini F, Pegreffi F, Paganelli G, Puccetti M, Bravaccini S. PMID: 42412051 [PubMed - as supplied by publisher]
	Detection of prostate cancer by magnetic resonance imaging before biopsy - real-world evidence from a nationwide cohort study. Scand J Urol Simoni AH, Ording A, Hedegaard JN, Borre M, Johnsen SP, Møller H. PMID: 42411569 [PubMed - indexed for MEDLINE]
	Diagnostic performance of 18F-prostate-specific membrane antigen-1007 PET/computed tomography and multiparametric MRI in prostate cancer: application of the PRIMARY score in a sub-Saharan African cohort. Nucl Med Commun Loyal PK, Olwit W, Shah J, Mwania M, Makhdomi K, Gitau SN. PMID: 42411249 [PubMed - as supplied by publisher]
	Correlation Between the Natural Course and Magnetic Resonance Imaging Features of Bacillus Calmette-GuÃ©rin-Related Granulomatous Prostatitis in Patients With Bladder Cancer. J Korean Med Sci Sim KC, Sung DJ, Han NY, Han YE, Park BJ, Kim MJ. PMID: 42411237 [PubMed - indexed for MEDLINE]
	Correction to "PruEV-AI: A Simple Approach Combines Urinary Extracellular Vesicle Isolation With AI-Assisted Analysis for Prostate Cancer Diagnosis". Small Methods PMID: 42410940 [PubMed - as supplied by publisher]
	Newly diagnosed high-risk localized prostate cancer after multiple [177Lu]Lu-PSMA radioligand therapy in the context of metastatic parotid carcinoma: a case report. J Med Case Rep Orf C, Handke AE, Noldus J, Roghmann F, Dellino M, Tully KH. PMID: 42410477 [PubMed - indexed for MEDLINE]
	A comprehensive plasma-based approach to thromboinflammation in bladder cancer: integrating lipidomics, thrombin generation, and NETosis biomarkers. J Transl Med Oto J, Herreros-Pomares A, Verger P, Herranz R, Plana E, Roca M, Pérez-Ardavín J, Vera-Donoso CD, Martínez-Sarmiento M, Bonanad S, Medina P. PMID: 42410426 [PubMed - as supplied by publisher]
	Renal toxicity during VEGF-pathway inhibition in cancer: a practical review of proteinuria, hypertension, and kidney-limited thrombotic microangiopathy. Clin Transl Oncol Corrêa LMA, Lourenço ALM, Brandão LKV, Mazur GR, Barbosa AA, Santiago CBG, Dutra Júnior IF, Husch RG, Delmiro Silva YR, de Santana GC, Dante LE. PMID: 42410275 [PubMed - as supplied by publisher]
	Challenges in postoperative self-management for patients with bladder cancer and urinary stoma: a qualitative study. Support Care Cancer Li Z, Fu Y, Zhang J, Wang Y, Shi T, Yu Q. PMID: 42410042 [PubMed - indexed for MEDLINE]
	Comparison of DeepSeek-V3.2 and ChatGPT-5.2 in the outpatient diagnosis and treatment of prostate cancer: a multicenter evaluation of application value and multilingual adaptability. Sci Rep Huang C, Wei Y, Xu N, Ju Z, Lin Z, Zhan B, Weng S, Lin R, Yin Y, Lin S, Chen S. PMID: 42409892 [PubMed - as supplied by publisher]
	Prostate-Specific Antigen Screening Patterns and Metastatic Prostate Cancer in US Veterans. JAMA Netw Open Siavoshi M, Frochen S, Fakunle M, Wadhwa A, Green-Lott AY, Bailey AV, Kwan L, Haroldsen C, Effiong A, Rose BS, Rebbeck TR, Iyer HS, Garraway IP. PMID: 42406398 [PubMed - indexed for MEDLINE]
	Next-Generation Checkpoint Combinations: Optimizing PD-(L)1-Based Therapy Across the Advanced, Adjuvant, and Neoadjuvant Settings. Curr Oncol Rep Petrelli F, Colombo Zefinetti L, D'Alessio A, Dottorini L, Ghidini A. PMID: 42406187 [PubMed - indexed for MEDLINE]
	Comparison of MRI-guided in-bore and fusion biopsy for small PI-RADS 4 prostate lesions. World J Urol Zoro, Madendere S, Tar, Veznikli M, Durmaz S, Vural M, Çil BE, Gürses B, Karaarslan U, Esen B, Kordan Y, Tilki D, Esen T. PMID: 42406173 [PubMed - indexed for MEDLINE]

Articles 1 - 20 / 179813

Page 1 of 8991



		Time frame

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Privacy Policy